Molecular Psychiatry - Table of Contents alert Volume 21 Issue 11

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 21, Issue 11 (November 2016) In this issue Image News and Commentary Reviews Original Articles Corrigenda Erratum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement A new open access journal dedicated to publishing the most important scientific advances in all aspects of genomics and its application in the practice of medicine. Part of the Nature Partner Journals series, the journal is published in partnership with the Center of Excellence in Genomic Medicine Research.  Open for submissions Image Top Misassembly of non-mutant full-length Disrupted-in-Schizophrenia 1 protein is induced by dopamine in vitro and in vivo V Bader, S V Trossbach, I Prikulis, S F Godsave, P J Peters and C Korth Mol Psychiatry 2016 21: 1487; 10.1038/mp.2016.190 Full Text | PDF News and Commentary Top DISC1 a key molecular lead in psychiatry and neurodevelopment: No-More Disrupted-in-Schizophrenia 1 M Niwa, T Cash-Padgett, K-I Kubo, A Saito, K Ishii, A Sumitomo, Y Taniguchi, K Ishizuka, H Jaaro-Peled, T Tomoda, K Nakajima, A Sawa and A Kamiya Mol Psychiatry 2016 21: 1488-1489; advance online publication, September 6, 2016; 10.1038/mp.2016.154 Full Text | PDF Reviews Top Dissecting bipolar disorder complexity through epigenomic approach OPEN B Ludwig and Y Dwivedi Mol Psychiatry 2016 21: 1490-1498; advance online publication, August 2, 2016; 10.1038/mp.2016.123 Abstract | Full Text | PDF The significance of selegiline/(−)-deprenyl after 50 years in research and therapy (1965–2015) I Miklya Mol Psychiatry 2016 21: 1499-1503; advance online publication, August 2, 2016; 10.1038/mp.2016.127 Abstract | Full Text | PDF Original Articles Top Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis OPEN N Yoshimi, T Futamura, S E Bergen, Y Iwayama, T Ishima, C Sellgren, C J Ekman, J Jakobsson, E Pålsson, K Kakumoto, Y Ohgi, T Yoshikawa, M Landén and K Hashimoto Mol Psychiatry 2016 21: 1504-1510; advance online publication, January 19, 2016; 10.1038/mp.2015.217 Abstract | Full Text | PDF Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis S Georgin-Lavialle, D S Moura, A Salvador, J-C Chauvet-Gelinier, J-M Launay, G Damaj, F Côté, E Soucié, M-O Chandesris, S Barète, C Grandpeix-Guyodo, C Bachmeyer, M-A Alyanakian, A Aouba, O Lortholary, P Dubreuil, J-R Teyssier, B Trojak, E Haffen, P Vandel, B Bonin, the French Mast Cell Study Group, O Hermine and R Gaillard Mol Psychiatry 2016 21: 1511-1516; advance online publication, January 26, 2016; 10.1038/mp.2015.216 Abstract | Full Text | PDF KCNH2-3.1 expression impairs cognition and alters neuronal function in a model of molecular pathology associated with schizophrenia G V Carr, J Chen, F Yang, M Ren, P Yuan, Q Tian, A Bebensee, G Y Zhang, J Du, P Glineburg, R Xun, O Akhile, D Akuma, J Pickel, J C Barrow, F Papaleo and D R Weinberger Mol Psychiatry 2016 21: 1517-1526; advance online publication, February 9, 2016; 10.1038/mp.2015.219 Abstract | Full Text | PDF In-depth neuropharmacokinetic analysis of antipsychotics based on a novel approach to estimate unbound target-site concentration in CNS regions: link to spatial receptor occupancy I Loryan, E Melander, M Svensson, M Payan, F König, B Jansson and M Hammarlund-Udenaes Mol Psychiatry 2016 21: 1527-1536; advance online publication, January 26, 2016; 10.1038/mp.2015.229 Abstract | Full Text | PDF Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials OPEN R-R Wu, F-Y Zhang, K-M Gao, J-J Ou, P Shao, H Jin, W-B Guo, P K Chan and J-P Zhao Mol Psychiatry 2016 21: 1537-1544; advance online publication, January 26, 2016; 10.1038/mp.2015.221 Abstract | Full Text | PDF Dopamine D2 receptors gate generalization of conditioned threat responses through mTORC1 signaling in the extended amygdala D De Bundel, C Zussy, J Espallergues, C R Gerfen, J-A Girault and E Valjent Mol Psychiatry 2016 21: 1545-1553; advance online publication, January 19, 2016; 10.1038/mp.2015.210 Abstract | Full Text | PDF Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users M Kohno, K Okita, A M Morales, C L Robertson, A C Dean, D G Ghahremani, F W Sabb, R A Rawson, M A Mandelkern, R M Bilder and E D London Mol Psychiatry 2016 21: 1554-1560; advance online publication, February 2, 2016; 10.1038/mp.2015.223 Abstract | Full Text | PDF Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits OPEN S V Trossbach, V Bader, L Hecher, M E Pum, S T Masoud, I Prikulis, S Schäble, M A de Souza Silva, P Su, B Boulat, C Chwiesko, G Poschmann, K Stühler, K M Lohr, K A Stout, A Oskamp, S F Godsave, A Müller-Schiffmann, T Bilzer, H Steiner, P J Peters, A Bauer, M Sauvage, A J Ramsey, G W Miller, F Liu, P Seeman, N J Brandon, J P Huston and C Korth Mol Psychiatry 2016 21: 1561-1572; advance online publication, January 12, 2016; 10.1038/mp.2015.194 Abstract | Full Text | PDF Predicting the functional states of human iPSC-derived neurons with single-cell RNA-seq and electrophysiology C Bardy, M van den Hurk, B Kakaradov, J A Erwin, B N Jaeger, R V Hernandez, T Eames, A A Paucar, M Gorris, C Marchand, R Jappelli, J Barron, A K Bryant, M Kellogg, R S Lasken, B P F Rutten, H W M Steinbusch, G W Yeo and F H Gage Mol Psychiatry 2016 21: 1573-1588; advance online publication, October 4, 2016; 10.1038/mp.2016.158 Abstract | Full Text | PDF Separating the wheat from the chaff: systematic identification of functionally relevant noncoding variants in ADHD J H S Tong, Z Hawi, C Dark, T D R Cummins, B P Johnson, D P Newman, R Lau, A Vance, H S Heussler, N Matthews, M A Bellgrove and K C Pang Mol Psychiatry 2016 21: 1589-1598; advance online publication, April 26, 2016; 10.1038/mp.2016.2 Abstract | Full Text | PDF Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features OPEN M Heidari, D M Johnstone, B Bassett, R M Graham, A C G Chua, M J House, J F Collingwood, C Bettencourt, H Houlden, M Ryten, J K Olynyk, D Trinder and E A Milward for the UK Brain Expression Consortium (UKBEC) Mol Psychiatry 2016 21: 1599-1607; advance online publication, January 5, 2016; 10.1038/mp.2015.192 Abstract | Full Text | PDF Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer’s disease with OSBPL6, PTPRG, and PDCL3 C Herold, B V Hooli, K Mullin, T Liu, J T Roehr, M Mattheisen, A R Parrado, L Bertram, C Lange and R E Tanzi Mol Psychiatry 2016 21: 1608-1612; advance online publication, February 2, 2016; 10.1038/mp.2015.218 Abstract | Full Text | PDF Increased ghrelin signaling prolongs survival in mouse models of human aging through activation of sirtuin1 OPEN N Fujitsuka, A Asakawa, A Morinaga, M S Amitani, H Amitani, G Katsuura, Y Sawada, Y Sudo, Y Uezono, E Mochiki, I Sakata, T Sakai, K Hanazaki, T Yada, K Yakabi, E Sakuma, T Ueki, A Niijima, K Nakagawa, N Okubo, H Takeda, M Asaka and A Inui Mol Psychiatry 2016 21: 1613-1623; advance online publication, February 2, 2016; 10.1038/mp.2015.220 Abstract | Full Text | PDF Shared genetic aetiology between cognitive functions and physical and mental health in UK Biobank (N=112 151) and 24 GWAS consortia OPEN S P Hagenaars, S E Harris, G Davies, W D Hill, D C M Liewald, S J Ritchie, R E Marioni, C Fawns-Ritchie, B Cullen, R Malik, METASTROKE Consortium, International Consortium for Blood Pressure GWAS, SpiroMeta Consortium, CHARGE Consortium Pulmonary Group, CHARGE Consortium Aging and Longevity Group, B B Worrall, C L M Sudlow, J M Wardlaw, J Gallacher, J Pell, A M McIntosh, D J Smith, C R Gale and I J Deary Mol Psychiatry 2016 21: 1624-1632; advance online publication, January 26, 2016; 10.1038/mp.2015.225 Abstract | Full Text | PDF Therapeutically relevant structural and functional mechanisms triggered by physical and cognitive exercise OPEN C Suo, M F Singh, N Gates, W Wen, P Sachdev, H Brodaty, N Saigal, G C Wilson, J Meiklejohn, N Singh, B T Baune, M Baker, N Foroughi, Y Wang, Y Mavros, A Lampit, I Leung and M J Valenzuela Mol Psychiatry 2016 21: 1633-1642; advance online publication, March 22, 2016; 10.1038/mp.2016.19 Abstract | Full Text | PDF Corrigenda Top Attention-deficit hyperactivity disorder in adults: a systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies OPEN C Bonvicini, S V Faraone and C Scassellati Mol Psychiatry 2016 21: 1643; advance online publication, August 9, 2016; 10.1038/mp.2016.128 Full Text | PDF Genome-wide analysis of over 106 000 individuals identifies 9 neuroticism-associated loci OPEN D J Smith, V Escott-Price, G Davies, M E S Bailey, L Colodro-Conde, J Ward, A Vedernikov, R Marioni, B Cullen, D Lyall, S P Hagenaars, D C M Liewald, M Luciano, C R Gale, S J Ritchie, C Hayward, B Nicholl, B Bulik-Sullivan, M Adams, B Couvy-Duchesne, N Graham, D Mackay, J Evans, B H Smith, D J Porteous, S E Medland, N G Martin, P Holmans, A M McIntosh, J P Pell, I J Deary and M C O'Donovan Mol Psychiatry 2016 21: 1644; advance online publication, September 13, 2016; 10.1038/mp.2016.177 Full Text | PDF Erratum Top Therapeutically relevant structural and functional mechanisms triggered by physical and cognitive exercise C Suo, M F Singh, N Gates, W Wen, P Sachdev, H Brodaty, N Saigal, G C Wilson, J Meiklejohn, N Singh, B T Baune, M Baker, N Foroughi, Y Wang, Y Mavros, A Lampit, I Leung and M J Valenzuela Mol Psychiatry 2016 21: 1645; advance online publication, April 19, 2016; 10.1038/mp.2016.57 Full Text | PDF Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Molecular Psychiatry. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.